Integra LifeSciences to Hold First International Tissue Technologies Symposium on June 16 - 17, 2016 in Lisbon, Portugal
(Thomson Reuters ONE) -
PLAINSBORO, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences
Holdings Corporation (NASDAQ:IART) today announced that it is holding its first
International Symposium on Tissue Technologies in Lisbon, Portugal, June 16 -
17, 2016.
This event-packed, two-day medical training symposium will bring together over
100 surgeons from Europe, the Middle East and the United States. The sessions
will offer an overview of surgical techniques used in various medical fields,
such as dermal reconstruction and regeneration, and plastic and reconstructive
procedures, which will be presented by a faculty of world-renowned surgeons.
"As a world leader in Tissue Technologies, Integra is very pleased to offer this
training and educational symposium, which will bring together some of the
world's leading plastic and reconstructive surgeons with Integra's regenerative
technology solutions," said Stephane Corp, Integra's Vice President, Orthopedics
& Tissue Technologies, EMEA . "Our vision is to provide soft tissue repair
technologies that improve patients' lives, and we are proud to host an event
where attendees can share best practices and techniques. We look forward to
working with the surgeons around the globe who share that vision to further
research in regenerative products and techniques."
This news release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
include, but are not limited to, statements concerning the products and services
provided by Integra. Such forward looking statements involve risks and
uncertainties that could cause actual results to differ materially from
predicted or expected results. Among other things, the willingness of surgical
professionals to use Integra products may affect the prospects for their use in
surgical procedures. In addition, the economic, competitive, governmental,
technological and other factors, identified under the heading "Risk Factors"
included in Item IA of Integra's Annual Report on Form 10-K for the year ended
December 31, 2015 and information contained in subsequent filings with the
Securities and Exchange Commission could affect actual results.
CONTACT: Integra LifeSciences Holdings Company
Investors
Angela Steinway
609-936-2268
angela.steinway(at)integralife.com
Michael Beaulieu
609-750-2827
michael.beaulieu(at)integralife.com
Media - United States
Gianna Sabella
609-775-8553
gianna.sabella(at)integralife.com
Media - Europe
Marie-Anne Girel
+33 437 475 970
marie-anne.girel(at)integralife.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Integra LifeSciences Holdings Corp. via GlobeNewswire
[HUG#2021060]
Datum: 16.06.2016 - 09:00 Uhr
Sprache: Deutsch
News-ID 478086
Anzahl Zeichen: 3468
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 232 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Integra LifeSciences to Hold First International Tissue Technologies Symposium on June 16 - 17, 2016 in Lisbon, Portugal"
steht unter der journalistisch-redaktionellen Verantwortung von
Integra LifeSciences Holdings Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
